Todd Druley
Has grant
Chief Scientific Officer for Hematology
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Todd Druley is the Chief Scientific Officer for Hematology at Danaher Corporation in the United States. His research focuses on clonal hematopoiesis, genetic mutations in high-risk neuroblastoma, and the clinical implications of sequencing strategies in hematological malignancies. He has published articles examining driver mutations in cancer, the outcomes of metastatic prostate cancer patients, and the evolutionary dynamics of clonal populations.
Recent Grants
Grant: Close
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
Open Date: 2016-12-09
Close Date: 2021-11-30
Grant: Close
Genomic Characterization of Chromatin Structure in Hematopoiesis
Open Date: 2016-06-01
Close Date: 2016-07-31
Grant: Close
Mechanisms and Risk Stratification for Treatment of Acute Myeloid Leukemia in Children with Down syndrome
Open Date: 2015-07-01
Close Date: 2020-06-30
Grant: Close
Mechanisms and Risk Stratification for Treatment of Acute Myeloid Leukemia in Children with Down syndrome
Open Date: 2015-07-01
Close Date: 2020-06-30
Grant: Close
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
Open Date: 2010-09-10
Close Date: 2015-08-31
Articles (6)
Year:
2025
Year:
2024
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (6)
Andrew Armstrong
Professor
Duke Cancer Institute
Wing Hing Wong
Stanford University
Satu-Liisa Pauniaho
Chief physician
Tampereen yliopisto
Irenaeus Chan
Washington University in St. Louis
Brian Miller
Assistant Professor
University of North Carolina at Chapel Hill
Jamie Rees Blundell
Professor
University of Cambridge
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.